Develops immunotherapies for cancer.
Dec 2024Revenue $0.00/yrExpenses $17.0M/yr
No trend
Figures by year
When will MAIA Biotechnology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $0.00 and expenses $17.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $0.00 | $17.0M | −$17.0M |
| Dec 2023 | $0.00 | $20.2M | −$20.2M |
| Dec 2022 | $0.00 | $16.2M | −$16.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.